Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add more filters










Database
Language
Publication year range
1.
Rev Mal Respir ; 29(5): 650-5, 2012 May.
Article in French | MEDLINE | ID: mdl-22682590

ABSTRACT

The study of pain in elderly patients with a primary lung cancer (PLC) deserves special attention particularly because this symptom is frequently associated with the condition and influences the management and prognosis. To study the characteristics of pain due to PLC in the elderly, we prospectively evaluated pain in all patients aged over 65 years admitted for PLC. Thirty-nine elderly patients were enrolled in 15 months (62% of all PLC). The average age was 72 years. The cancer was advanced NSCLC in most cases. Pain was present in 74.3%. It was significantly less common among those over 75 years (50% versus 85.1%; P<0.05). The pain, mild in most cases, worsened during follow-up in 55.5%. The last mean visual analogue scale score was significantly lower than the first (1.3 versus 3.6; P=0.001). The pain treatment required was based on level I in 20.6%, level II in 48.2% and level III in 31% of cases. Pain management in the elderly should be early, adequate and continued in order to preserve to a maximum the quality of life of these patients with PLC.


Subject(s)
Aged , Carcinoma, Non-Small-Cell Lung/complications , Lung Neoplasms/complications , Pain Management , Pain/etiology , Adenocarcinoma/complications , Adenocarcinoma/epidemiology , Adenocarcinoma/therapy , Age of Onset , Aged, 80 and over , Analgesics/therapeutic use , Carcinoma, Non-Small-Cell Lung/epidemiology , Carcinoma, Non-Small-Cell Lung/therapy , Carcinoma, Squamous Cell/complications , Carcinoma, Squamous Cell/epidemiology , Carcinoma, Squamous Cell/therapy , Disease Progression , Hospitalization/statistics & numerical data , Humans , Lung Neoplasms/epidemiology , Lung Neoplasms/therapy , Male , Pain/diagnosis , Pain/epidemiology , Pain Management/methods , Pain Management/statistics & numerical data , Pain Measurement
2.
Rev Pneumol Clin ; 67(6): 354-8, 2011 Dec.
Article in French | MEDLINE | ID: mdl-22137279

ABSTRACT

Drug-induced muscle disorders are now well known and vary from a simple isolated increase in muscle enzymes to severe drug-induced myopathy. The list of drugs inducing myopathy is very long and continues to grow. The onset of muscle disorders under isoniazid often falls within a drug-induced neuropathy or a drug-induced lupus. However, the occurrence of isolated isoniazid-induced drug myopathy without neuropathy is an extremely rare condition especially with non-toxic doses. The authors report the case of a 28-year-old man, without a previous medical history, hospitalized for pulmonary tuberculosis. After initiating tuberculosis treatment for five days, he presented muscle pain, fasciculation and weakness initially involving the lower left limb that quickly propagated to all four limbs. The physical examination noted a left ankle flush, a swollen left calf and fasciculation of both calves while the neurological examination was normal. The CPK was normal. Electromyography confirmed the myopathy without neuropathic findings. Isoniazid withdrawal was marked by the rapid disappearance of the symptoms. The reintroduction of a half-dose of isoniazid only induced a few transitional muscular fasciculations. The onset of the symptoms under tuberculosis treatment, the absence of later muscle disorders, the absence of any other cause of myopathy and the total disappearance of the symptoms after isoniazid withdrawal confirmed the diagnosis of isoniazid-induced myopathy.


Subject(s)
Isoniazid/adverse effects , Muscular Diseases/chemically induced , Adult , Antitubercular Agents/adverse effects , Humans , Male , Muscular Diseases/diagnosis , Muscular Diseases/diagnostic imaging , Radiography, Thoracic
SELECTION OF CITATIONS
SEARCH DETAIL
...